Subconjunctival delivery of antibiotics in a controlled-release system: A novel anti-infective prophylaxis approach for cataract surgery

Archives of Ophthalmology

Volumn 128, Issue 1, 2010, Pages 81-87

  Cardillo, José A ^a,b,c   Paganelli, Fernando ^a,b,c   Melo Jr , Luiz A S ^b   Silva Jr , Arnobio A ^d   Pizzolitto, Antonio C ^d   Oliveira, Anselmo G ^d   Belfort Jr , Rubens ^e   Costa, Rogerio A ^e   Franzini, Cristina M ^e   Kuppermann, Baruch D ^e   Lima Filho, Acacio A S ^e   Lavinsky, Daniel ^e   Höfling Lima, Ana L ^e   Nguyen, Quan Dong ^e   Schellini, Silvana A ^e   Skaf, Mirian ^e  

^a Hospital de Olhos de Araraquara   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Centro Universitario de Araraquara   (Brazil)

^d SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

BALANCED SALT SOLUTION; CIPROFLOXACIN; CIPROFLOXACIN PLUS TRIAMCINOLONE; DUOCAT; EYE DROPS; TRIAMCINOLONE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; DRUG CARRIER; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR EYE CHAMBER; ANTIBIOTIC PROPHYLAXIS; AQUEOUS HUMOR; ARTICLE; BACTERIUM CULTURE; CATARACT EXTRACTION; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG EFFICACY; ENDOPHTHALMITIS; FEMALE; HISTOLOGY; INFECTION PREVENTION; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SINGLE DRUG DOSE; STAPHYLOCOCCUS AUREUS; VITREOUS BODY; ANIMAL; BACTERIAL EYE INFECTION; BIOAVAILABILITY; COMPARATIVE STUDY; CONJUNCTIVA; DELAYED RELEASE FORMULATION; DRUG COMBINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIBIOTIC PROPHYLAXIS; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; CATARACT EXTRACTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; CONJUNCTIVA; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG THERAPY, COMBINATION; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; LACTIC ACID; POLYGLYCOLIC ACID; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRIAMCINOLONE; VITREOUS BODY;

EID: 75349093748     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.352     Document Type: Article

References (20)

1. Schein OD. Prevention of endophthalmitis after cataract surgery: making the most of the evidence. Ophthalmology. 2007;114(5):831-832.
2. Järvinen K, Järvinen T, Urtti A. Ocular absorption following topical delivery. Adv Drug Deliv Rev. 1995;16:3-19.
3. Lang JC. Ocular drug delivery: conventional ocular formulations. Adv Drug Deliv Rev. 1995;16:39-43.
4. Behrens-Baumann W, Martell J. Ciprofloxacin concentration in the rabbit aqueous humor and vitreous following intravenous and subconjunctival administration. Infection. 1988;16(1):54-57.
5. Barza M. Antibacterial agents in the treatment of ocular infections. Infect Dis Clin North Am. 1989;3(3):533-551.
6. Geroski DH, Edelhauser HF. Transscleral drug delivery for posterior segment disease. Adv Drug Deliv Rev. 2001;52(1):37-48.
7. Starr MB, Lally JM. Antimicrobial prophylaxis for ophthalmic surgery. Surv Ophthalmol. 1995;39(6):485-501.
8. Clements DB, Tailor V. A study of aqueous and serum levels of ceftazidine following subconjunctival administration. Br J Ophthalmol. 1987;71(6):433-435.
9. Prausnitz MR, Noonan JS. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci. 1998;87(12):1479-1488.
10. Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. Am J Ophthalmol. 2004;138(1):33-37.
11. Levine JM, Noecker RJ, Lane LC, Herrygers L, Nix D, Snyder RW. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing. J Cataract Refract Surg. 2004;30(10):2177-2182.
12. Solomon R, Donnenfeld ED, Perry HD, et al. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology. 2005;112(3):466-469.
13. Kim DH, Stark WJ, O'Brien TP, Dick JD. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Ophthalmology. 2005;112(11):1992-1996.
14. Hermann MM, Ustundag C, Diestelhorst M. Compliance with topical therapy after cataract surgery using a new microprocessor-controlled eyedrop monitor [abstract]. Invest Ophthalmol Vis Sci. 2005;46:E-Abstract 3832.
15. Kompella UB, Bandi N, Ayalasomayajula SP. Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest Ophthalmol Vis Sci. 2003;44(3):1192-1201.
16. Gilbert JA, Simpson AE, Rudnick DE, Geroski DH, Aaberg TM Jr, Edelhauser HF. Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix. J Control Release. 2003;89(3):409-417.
17. Hosoya K, Lee VH, Kim K. Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation. Eur J Pharm Biopharm. 2005;60(2):227-240.
18. Saishin Y, Silva RL, Saishin Y, et al. Periocular injection of microspheres containing PKC412 inhibits choroidal neovascularization in a porcine model. Invest Ophthalmol Vis Sci. 2003;44(11):4989-4993.
19. Kimura H, Ogura Y, Moritera T, et al. Injectable microspheres with controlled drug release for glaucoma filtering surgery. Invest Ophthalmol Vis Sci. 1992;33 (12):3436-3441.
20. Paganelli F, Cardillo JA, Melo LA Jr, et al; Brazilian Ocular Pharmacology and Pharmaceutical Technology Research Group. A single intraoperative subtenon's capsule injection of triamcinolone and ciprofloxacin in a controlledrelease system for cataract surgery. Invest Ophthalmol Vis Sci. 2009;50(7): 3041-3047.